This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why Etsy Stock Is Soaring Today
by Benjamin Rains
Shares of Etsy Inc. (ETSY) are soaring on Tuesday morning after reports that activist investors are pushing for big changes at the struggling e-commerce company.
Zacks.com featured highlights: Covanta Holding, PTC, Etsy, KCG Holdings and Incyte
by Zacks Equity Research
Zacks.com featured highlights: Covanta Holding, PTC, Etsy, KCG Holdings and Incyte
Etsy Stock Plummets 16% After Q1 Revenue Miss, CEO Resigns
by Benjamin Rains
Etsy Inc. (ETSY) just released its first quarter 2017 financial results, posting breakeven earnings and revenues of $97 million. Currently, Etsy is a Zacks Rank #3 (Hold), and is down 15.72% to $9.60 per share in after-hours trading shortly after its earnings report was released.
5 Toxic Stocks to Dispose of or Play Short for Profit
by Zacks Equity Research
Just like picking stocks with growth potential, pinpointing toxic stocks and discarding them at the right time is the key to shield your portfolio from big losses or make profits by short selling them.
eBay (EBAY) Beats Earnings and Revenue Estimates in Q1
by Zacks Equity Research
eBay Inc.'s (EBAY) first-quarter 2017 earnings and revenues came ahead of expectations.
Zacks.com featured highlights: PTC, Covanta Holding, Etsy, Incyte and AMAG Pharmaceuticals
by Zacks Equity Research
Zacks.com featured highlights: PTC, Covanta Holding, Etsy, Incyte and AMAG Pharmaceuticals
5 Toxic Stocks to Get Rid Of or Play Short to Make Gains
by Zacks Equity Research
Exaggerated price of toxic stocks can be attributed to either an irrational exuberance associated with them or some serious fundamental lacuna.
eBay Ups Data Science Focus with New Advertising Strategy
by Zacks Equity Research
eBay Inc.???s (EBAY) eBay Advertising unit unveiled a new advertising strategy and announced a record 48% growth in advertising customer count in 2016.
Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals
by Zacks Equity Research
Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals
Etsy Stock Tumbles Despite Earnings Beat, Strong Revenue Growth
by Joseph Lu
Etsy Inc. (ETSY) just released its fourth quarter financial results of 2016, posting earnings of $0.03 per share and revenues of $110.2 million.
Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Vertex Pharmaceuticals, Etsy and Incyte
by Zacks Equity Research
Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Vertex Pharmaceuticals, Etsy and Incyte
Zacks.com featured highlights: Ets, Incyte, Abercrombie & Fitch, Vertex Pharmaceuticals and Bottomline Technologies
by Zacks Equity Research
Zacks.com featured highlights: Ets, Incyte, Abercrombie & Fitch, Vertex Pharmaceuticals and Bottomline Technologies
Zacks.com featured highlights: Live Nation Entertainment, Conns, ConocoPhillips, Etsy and Incyte
by Zacks Equity Research
Zacks.com featured highlights: Live Nation Entertainment, Conns, ConocoPhillips, Etsy and Incyte
eBay (EBAY) Q4 Earnings Lag, Holiday Sales Drive Revenues
by Zacks Equity Research
eBay Inc. (EBAY) fourth-quarter 2016 revenues were up sequentially and year over year. Shares jumped more than 8% in extended trading on Wednesday.
Zacks.com featured highlights: Abercrombie & Fitch, Etsy, Conns, Covanta Holding and ConocoPhillips
by Zacks Equity Research
Zacks.com featured highlights: Abercrombie & Fitch, Etsy, Conns, Covanta Holding and ConocoPhillips
Zacks Investment Ideas feature highlights: Etsy, IAC/InterActive, Boeing, United Technologies and Kate Spade
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Etsy, IAC/InterActive, Boeing, United Technologies and Kate Spade
Which Rumored Deals Should You Buy?
by Brian Bolan
There are plenty of rumors of acquisitions floated on a daily basis, wise investors leverage the Zacks Rank to get an edge.
The Zacks Analyst Blog Highlights: Cabot Oil & Gas, Zayo Group Holdings, Etsy, Live Nation Entertainment and Vertex Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cabot Oil & Gas, Zayo Group Holdings, Etsy, Live Nation Entertainment and Vertex Pharmaceuticals
Etsy (ETSY) Posts In-Line Q3 Earnings, Misses Revenue Expectations
by Ryan McQueeney
Etsy, Inc. (ETSY) just released its third-quarter earnings results, posting earnings of -$0.02 per share and revenue of $87.6 million.
Bear of the Day: Etsy (ETSY)
by Tracey Ryniec
Handmade goods are hot so why isn't Etsy profitable?
Bear of the Day: Linkedin (LNKD)
by Jeremy Mullin
Lower guidance and lower estimates equals lower stock price.